CalciMedica Inc
NASDAQ:CALC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CalciMedica Inc
NASDAQ:CALC
|
US |
Intrinsic Value
The intrinsic value of CalciMedica Inc (CALC) under the Base Case is 4.6 USD per share. Compared with the current market price of 1.15 USD, the stock appears Undervalued by 75% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What CalciMedica Does
CalciMedica, Inc. operates as a biopharmaceutical company. The company is headquartered in La Jolla, California and currently employs 8 full-time employees. The company went IPO on 2020-09-25. The firm is focused on developing therapies for life-threatening inflammatory diseases with high unmet needs. Its technology targets the inhibition of Calcium Release-Activated Calcium (CRAC) channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases.
- Headquarters
- United States of America US
- Employees
- 8
- IPO date
- Sep 25, 2020
Earnings Waterfall
CalciMedica Inc
The intrinsic value for CalciMedica Inc (CALC) under the Base Case is 4.6 USD.
Compared with the current market price of 1.15 USD, the stock appears Undervalued by 75% .